MedPath

CARDIZEM INJECTABLE LIQ 5MG/ML

CARDIZEM INJECTABLE LIQ 5MG/ML

Discontinued
DIN Number

02048620

Drug Class

Human

Market Date

Dec 31, 1993

Company
HC

labs nordic laboratories inc. - subsidary of m.m.d.c.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02048620
AIG Number0115863003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C08DB01 DILTIAZEM
Product Specifications
Dosage FormLiquid
Route of AdministrationIntravenous
AHFS Classification24:28.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

DILTIAZEM HYDROCHLORIDEActive
Strength: 5 MG / ML
Monograph: DILTIAZEM HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.